Idorsia Ltd. & Idorsia Pharmaceuticals, US Inc. i aso nei ua fa'ailoa mai o QUVIVIQ ™ (daridorexant) CIV 25 mg ma 50 mg tablets o lo'o avanoa nei fa'apisinisi mo tagata matutua e maua i le le mautonu, lea e fa'aalia i le fa'alavelave i le pa'u po'o le moe.
O le le mautonu o se tulaga o le soona gaioi o le faiʻai i le taimi o le moe, ma o suʻesuʻega ua faʻaalia ai o vaega o le faiʻai e fesoʻotaʻi ma le fafagu e tumau pea le malosi i le taimi o le moe i tagata mamaʻi e maua i le le mautonu. O le le mautonu o le moe sili lea ona taatele, e aafia ai le sili atu i le 25 miliona tagata matutua i le US.2 Le lelei poʻo le le lava o le moe e mafai ona aʻafia ai le tele o itu o le olaga i aso uma o tagata e faʻalavelave moe, e aofia ai le mafai ona faʻamalosi, lagona ma le malosi.4 I se taimi umi, o le le mautonu e fesoʻotaʻi ma le tele o tulaga faʻalesoifua maloloina ogaoga, e pei o faʻafitauli o le mafaufau, faʻamaʻi cardiovascular, faʻaaogaina o vailaʻau ma le tuinanau.5,6,7
O le QUVIVIQ o se fa'afeagai e lua o le orexin receptor, lea e poloka ai le fusifusia o le fafagu-fa'alauiloa neuropeptides orexins ma e manatu e fa'aitiitia ai le so'ona mataala i le ma'i moe. le itiiti ifo ma le fitu itula o totoe a'o le'i fafagu fuafuaina.
Patricia Torr, Peresitene ma Pule Sili o Idorsia US, fai mai:
"Ina ua maeʻa tausaga faʻamaoni i le suʻesuʻeina o le saienisi o le moe ma le orexin system, o aso nei o se mea taua tele mo Idorsia, ona o le oloa muamua a le kamupani i le US ua avanoa nei mo tagata mamaʻi."
OA MEA E AVEA MAI LENEI TUSI:
- “After years dedicated to researching the science of sleep and the orexin system, today is a momentous milestone for Idorsia, as the company’s first product in the US is now available to patients.
- Insomnia is a condition of overactive brain activity during sleep, and studies have shown that areas of the brain associated with wakefulness remain more active during sleep in patients with insomnia.
- QUVIVIQ is a dual orexin receptor antagonist, which blocks the binding of the wake-promoting neuropeptides orexins and is thought to turn down overactive wakefulness in insomnia.
